CorMedix Inc (NASDAQ: CRMD) on Friday, plunged -4.18% from the previous trading day, before settling in for the closing price of $11.71. Within the past 52 weeks, CRMD’s price has moved between $3.61 and $17.43.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 29.80% over the last five years. The company achieved an average annual earnings per share of 455.24%. With a float of $72.39 million, this company’s outstanding shares have now reached $74.43 million.
The firm has a total of 65 workers. Let’s measure their productivity. In terms of profitability, gross margin is 95.19%, operating margin of 17.53%, and the pretax margin is 20.81%.
CorMedix Inc (CRMD) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CorMedix Inc is 2.75%, while institutional ownership is 32.01%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 455.24% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
CorMedix Inc (CRMD) is currently performing well based on its current performance indicators. A quick ratio of 3.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.23, a number that is poised to hit 0.17 in the next quarter and is forecasted to reach 1.79 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
Analysing the last 5-days average volume posted by the [CorMedix Inc, CRMD], we can find that recorded value of 1.35 million was lower than the volume posted last year of 1.71 million. As of the previous 9 days, the stock’s Stochastic %D was 13.61%.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 47.51%, which indicates a significant increase from 1.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.65 in the past 14 days, which was higher than the 0.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.54, while its 200-day Moving Average is $10.42. Now, the first resistance to watch is $11.57. This is followed by the second major resistance level at $11.92. The third major resistance level sits at $12.11. If the price goes on to break the first support level at $11.03, it is likely to go to the next support level at $10.84. Now, if the price goes above the second support level, the third support stands at $10.49.
CorMedix Inc (NASDAQ: CRMD) Key Stats
Market capitalization of the company is 835.10 million based on 67,825K outstanding shares. Right now, sales total 43,470 K and income totals -17,930 K. The company made 39,080 K in profit during its latest quarter, and 20,640 K in sales during its previous quarter.
